Zhejiang Conba Pharmaceutical Co (SHSE:600572) GF Score : 75/100 (As of Apr. 25, 2025)

View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Conba Pharmaceutical Co GF Score?

Zhejiang Conba Pharmaceutical Co has the GF Score of 75, which implies that the company is Likely to have average performance.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 6/10
3. Growth Rank : 8/10
4. GF Value Rank : 8/10
5. Momentum Rank : 2/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Zhejiang Conba Pharmaceutical Co is Likely to have average performance.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Zhejiang Conba Pharmaceutical Co's GF Score

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Conba Pharmaceutical Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Conba Pharmaceutical Co's GF Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Conba Pharmaceutical Co's GF Score distribution charts can be found below:

* The bar in red indicates where Zhejiang Conba Pharmaceutical Co's GF Score falls into.

Save Embed

;

Save Embed

;

Zhejiang Conba Pharmaceutical Co (SHSE:600572) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Zhejiang Conba Pharmaceutical Co GF Score Related Terms

Thank you for viewing the detailed overview of Zhejiang Conba Pharmaceutical Co's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Conba Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) » Definitions » GF Score

Traded in Other Exchanges

N/A

Address

No. 568 Binkang Road, New and High-Technology Development Zone, Binjiang District, Zhejiang, Hangzhou, CHN, 310052

Website

http://www.conba.com.cn

Zhejiang Conba Pharmaceutical Co Ltd operates as a pharmaceutical company in China. It offers traditional Chinese medicines, botanical extracts, chemical medicines, chemical raw medicines, health foods, common foods, prepared drugs in pieces, and commodities. It provides its products under the Conba, Prostate Plus, Zhenshiming, Tianbaoning, Alocin, Xitao, Yuanbang, Baby, and Omeprazole names.

Executives

Hu Ji Qiang	Director
Yuan Zhen Xian	senior management
Yin Shi Shui	Supervisors
Xu Chun Ling	senior management
Jin Zu Cheng	Directors, senior managers
Ye Jian Feng	Supervisors
Ying Chun Xiao	Director
Chen Ming	Director
Luo Guo Liang	Director
Wu Zhong Shi	Supervisors
Wang Ru Wei	Director
Yang Jun De	senior management
Yang Xian Min	senior management
Chen Yue Zhong	senior management
Li Jian Zhong	Supervisors

Zhejiang Conba Pharmaceutical Co Headlines

No Headlines